FDA grants emergency use authorization for Regeneron Pharmaceutical’s REGEN-COV2 antibody cocktail

On Saturday November 21, 2020 the FDA granted an emergency use authorization (EAU) for the antibody cocktail used to treat President Trump back in October.

The antibody cocktail is known as REGEN-COV2 and is manufactured by Regeneron Pharmaceuticals. As you may know, this will most likely cause a stir in the stock market tomorrow morning. As of 11:54 am MST, their stock (REGN) is listed at $518.74.

We will reach out to the local IHS facility to ask when they may receive this new antibody cocktail. Remember, you can also reach out to your village Council Representatives to ask when Hopi will receive the COVID-19 vaccine and doses of REGEN-COV2.

Below are some useful links to keep you informed: